CYTK vs DHR · rev $28.6M vs P/E 39, rev $6.26B
Cytokinetics Inc (CYTK) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
CYTK currently screens at market cap $4.05B. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the CYTK and DHR stock pages for the full models.
Not investment advice.